Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,037
+$245 QoQ
Shares Held
13
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,590
of 1,603 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Luminist Capital LLC holds $56,166 across 8 Drug Manufacturers - General names. NVS ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
85 | $21,586 | |
| 2 | ABBV |
AbbVie Inc.
|
34 | $8,555 | |
| 3 | MRK |
Merck & Co., Inc.
|
58 | $7,452 | |
| 4 | LLY |
ELI LILLY & Co
|
5 | $5,997 | |
| 5 | AMGN |
Amgen Inc
|
15 | $5,431 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
47 | $2,708 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19 | $2,400 | |
| 8 | NVS |
Novartis AG
This page
|
13 | $2,037 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,037 | 13 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $1,792 | 13 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||